Eli Lilly Pharmaceuticals Engliflozin has been approved for indications for adult chronic kidney disease in China
阿豆学长长ov
发表于 2023-11-24 18:17:46
254
0
0
On November 24, Lilly Pharmaceutical and Boehringer Ingelheim jointly announced that Outangjing& Reg; The new indication of Engliflozin has been approved by the National Drug Administration of China for the treatment of adult chronic kidney disease (CKD).
This is after adult type 2 diabetes, adult heart failure with reduced ejection fraction, adult heart failure with preserved ejection fraction, and combined insulin treatment of type 2 diabetes; Reg; Another new indication approved in China. In addition to the existing indications for type 2 diabetes and heart failure, Ou Tangjing& Reg; Helps manage risks caused by cardiovascular metabolic diseases. Since its listing, it has benefited over 1 billion patients worldwide.
Liu Zhihong, an academician of the CAE Member and director of the National Clinical Medical Research Center for Renal Diseases, said that chronic kidney disease is a major disease threatening public health around the world. In China, because of the improvement of public education, medical services and environmental protection in the past decade, the prevalence of CKD among adults over 18 years old has dropped from 10.8% to 8.2%. But because of the high incidence rate of CKD, the high rate of combined cardiovascular disease, and the high rate of death and disability; The "three highs and three lows" characteristics of low awareness rate, low consultation rate, and low control rate still impose a considerable burden on patients, their families, and even society. This approval has enabled Ou Tangjing to; Reg; Bringing safe and effective new treatment options to Chinese patients is expected to improve the treatment prospects of more CKD patients.
CandyLake.com 系信息发布平台,仅提供信息存储空间服务。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
猜你喜欢
- Most popular Chinese concept stocks rose on Friday, with the Nasdaq China Golden Dragon Index up 4% and NIO up over 12%
- Popular Chinese concept stocks rise, NASDAQ China Golden Dragon Index rises by about 4%
- 3.3 billion yuan! NIO China receives a new round of capital increase from strategic investors
- NIO China receives a new round of strategic investment and capital increase
- 3.3 billion yuan! NIO China receives a new round of capital increase from strategic investors
- NIO China receives a new round of capital increase from strategic investors
- NIO China receives a new round of 3.3 billion yuan capital increase from strategic investors
- Moving towards a bull market? China's massive easing boosts Bitcoin outlook to $70000
- On Monday, popular Chinese concept stocks closed with mixed gains and losses. The Nasdaq China Golden Dragon Index rose about 30% in September
- Nike's revenue fell by 10% in the last quarter: net profit decreased by nearly 30%, and sales in China decreased by 4%
-
9月が終わり、映画・テレビ業界が暗躍している。最近、愛奇芸の創始者でCEOのGONG宇氏は、映画・テレビ業界が長短の変化、AIの変化、中国映画・テレビドラマの海外進出の変化の3つの変化を経験していると発表した。 ...
- 寒郁轩良
- 3 天前
- 支持
- 反对
- 回复
- 收藏
-
10月1日、理想自動車が9月に納入したデータによると、9月に理想自動車が新車53709台を納入し、前年同月比48.9%増となった。 今年第3四半期、理想自動車は前年同期比45.4%増の152831台を納入した。今年9月30日現在、 ...
- 就放荡不羁就h
- 昨天 12:06
- 支持
- 反对
- 回复
- 收藏
-
ネットワーク状況監視サイトDownDetectorによると、オーディオストリーミングプラットフォームSpotifyは日曜日に約3時間にわたる障害を経験した後、正常に回復し、ピーク時には米国の4万人以上のユーザーに影響を与 ...
- hecgdge4
- 3 天前
- 支持
- 反对
- 回复
- 收藏
-
10月1日、極クリプトン自動車が発表したデータによると、今年第3四半期に新車が累計14万2900台納入され、前年同期比81%増となった。このうち、9月に新車を納入したのは2万13万人で、前年同期比77%、前月比18%増だっ ...
- 内托体头
- 前天 16:17
- 支持
- 反对
- 回复
- 收藏